Efficacy and Safety of Neoadjuvant Sintilimab Plus FLOT Versus Sintilimab Plus SOX Phase II Clinical Trial for Patients With Locally Advanced Gastric Cancer

NCT06459921 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Neoadjuvant Chemotherapy
Sintilimab
Locally Advanced Gastric Cancer

Interventions

DRUG: SOX+Sintilimab
DRUG: FLOT+Sintilimab

Sponsor

Xijing Hospital